TGF-β1 and TGF-β2 abundance in liver diseases of mice and menAnne Dropmann(University Hospital Heidelberg), Nadja M. Meindl‐Beinker(University Hospital Heidelberg)OncotargetJanuary 21, 201610.18632/oncotarget.6967Cited by 61SaveCiteExport RISWatch citationsRelated PapersComparative Analysis of TGF-β/Smad Signaling Dependent Cytostasis in Human Hepatocellular Carcinoma Cell Lines|PLoS ONE|2013|80Smad7 regulates compensatory hepatocyte proliferation in damaged mouse liver and positively relates to better clinical outcome in human hepatocellular carcinoma|Clinical Science|2015|30